- $9.64bn
- $10.46bn
- $1.51bn
- 78
- 14
- 58
- 48
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 824 | 843 | 1,024 | 1,246 | 1,514 |
Cost of Revenue | |||||
Gross Profit | 368 | 341 | 382 | 473 | 647 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 790 | 863 | 1,115 | 1,309 | 1,381 |
Operating Profit | 34.3 | -20 | -90.3 | -62.9 | 133 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 34.3 | -20 | -90.3 | -62.9 | 96 |
Provision for Income Taxes | |||||
Net Income After Taxes | 78.7 | -4 | -75.4 | -73.4 | 54.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 78.7 | -4 | -75.4 | -73.4 | 54.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 78.7 | -4 | -75.4 | -73.4 | 54.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.529 | 0.124 | -0.445 | -0.28 | 0.363 |